**bioAffinity Technologies Reports Results of 2024 Special Meeting**

bioAffinity Technologies, Inc. (NASDAQ: BIAF) recently held its 2024 Special Meeting of Stockholders on December 20, 2024, where pivotal decisions were made concerning the company’s future. At the meeting, stockholders voted on two critical proposals detailed in the Company’s definitive proxy statement filed on November 22, 2024. In Proposal No. 1, which pertained to the […]

Leave a Reply

Your email address will not be published.

Previous post Kirkland’s Target of Unusually High Options Trading (NASDAQ:KIRK)
Next post Chenghe Acquisition I Co. Shareholders Approve Business Combination Agreement and Name Change